Rozanolixizumab (Anti-FcRn (FCGRT & B2M))Rozanolixizumab (Anti-FcRn (FCGRT & B2M))
Move your mouse over image or click to enlarge

Rozanolixizumab (Anti-FcRn (FCGRT & B2M))

Rozanolixizumab (Anti-FcRn (FCGRT & B2M)) is a high-affinity humanized monoclonal antibody, targeting human neonatal Fc receptor (FcRn) and is used to the research of reducing pathogenic IgG in autoimmune and alloimmune diseases. MW: 150 KD.
Cat# Size Price Qty Buy
A2500-1mg*25 1mg*25
£2,432.00
A2500-1mg*5 1mg*5
£794.00
A2500-1mg 1mg
£303.00

Additional Information

Property Value or Rating
Manufacturer Selleck Chemicals LLC
Manufacturer Cat# A2500

Related Documents